RBI rejects Rakesh Asthana’s appointment to Religare’s board

The Reserve Bank of India has refused to approve Religare Enterprises’ application to appoint Rakesh Asthana as a director on its board, the company said in an exchange filing on Thursday.

“…it is advised that your proposal to appoint Sh. Rakesh Asthana as a director on the board of Religare Enterprises Limited does not have the approval of the Reserve Bank of India,” the central bank said in a letter to the company dated May 15.

Last November, the Religare’s board appointed Asthana, former police commissioner of Delhi and CBI special director, as an additional director and to be designated as a whole-time director, subject to shareholder and regulatory approvals.

Also ReadAdani Wilmar swings back to black with profit at Rs 311.02 crore, revenue rises by 17.9% YoY

Three months after the board approval, the Burman family, which holds almost 26% stake in Religare, had opposed the appointment. They had written to the Securities and Exchange Board of India (SEBI) alleging that the mandatory shareholder approval was not taken within three months of his appointment and was a breach of its rules.

Religare and Rakesh Asthana were initially contemplating writing to the RBI seeking a review for reconsideration the application but couldn’t as the company was “busy in preparing for the herculean task of making ready multiple applications to regulators in respect of change of shareholding/ control/ management of the company and its group entities,” in relation to the Burmans open offer.

The company and its committee of independent directors had raised concerns regarding the acquirers, its promoters and directors, which were being forwarded to the market regulator with a request to conduct a detailed investigation, it said.

Further, the company also missed disclosing this communication to the stock exchanges earlier due to an oversight. “In this rush and with the focus shifting on filing regulatory applications etc the issue of refusal of approval by RBI for appointment of Shri Asthana being taken up with RBI for redressal reconsideration got missed and in this state of events, the fact of not making the disclosure under SEBI LODR was also missed due to oversight,” the company said.

Also ReadIndia-Germany Dialogue to Focus on Skilled Labor and India-EU Trade Deal

Religare’s management,

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations